J.Henderson Gl.Life Sciences F.A2/ IE0009355771 /
| NAV2024-04-25 | Chg.-0.1400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 51.5900USD | -0.27% | reinvestment | Equity | Janus Henderson Inv. ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-04-26 | Public WebStation Live Factsheet | 2024 | English | - |
| 2023-12-29 | Prospectus | 2023 | English | 4,732.84 KB |
| 2023-12-29 | Prospectus | 2023 | German | 4,893.26 KB |
| 2023-12-11 | PRIIP Key Information Document | 2023 | German | 118.97 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 6,997.79 KB |
| 2022-12-31 | Account statment | 2022 | English | 3,262.09 KB |
| 2022-12-31 | Account statment | 2022 | German | 3,512.75 KB |
| 2022-10-01 | Key Investor Information | 2022 | German | 140.18 KB |
| 2022-06-30 | Semi-annual report | 2022 | German | 4,631.53 KB |
| 2022-02-11 | Key Investor Information | 2022 | English | 139.45 KB |
